6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patients.


Journal

Clinical and experimental immunology
ISSN: 1365-2249
Titre abrégé: Clin Exp Immunol
Pays: England
ID NLM: 0057202

Informations de publication

Date de publication:
19 08 2022
Historique:
received: 31 01 2022
revised: 17 05 2022
accepted: 24 06 2022
pubmed: 28 6 2022
medline: 24 8 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis, microangiopathy, and autoantibodies. We previously reported that circulating follicular helper T (cTfh) cells are increased in SSc and induce plasmablast differentiation. However, mechanisms leading to cTfh cell expansion and activation in SSc remain to be established. Tfh cells require IL-12 for their expansion and differentiation. 6-Sulfo LacNAc monocytes (slanMo), a subset of monocytes, have a higher capacity to produce IL-12 and to induce CD4+ T cell proliferation in comparison with dendritic cells (DC) or classical monocytes. The aim of this study was to perform a quantitative and functional analysis of monocytes and DC and to correlate them with cTfh cell expansion and clinical manifestations in SSc. Using flow cytometry, we analyzed different monocyte subsets including slanMo and DC from 36 SSc patients and 26 healthy controls (HC). In vitro culture experiments of sorted slanMo were performed for functional analysis and cytokine production. We observed that slanMo, intermediate and non-classical monocytes were increased in SSc in comparison with HC. Furthermore, the increase in slanMo cells was more potent in patients with diffuse SSc. We observed a significant positive correlation between slanMo and cTfh cell levels in SSc patients but not in HC. Other monocyte subsets did not correlate with cTfh cell expansion. In addition, we observed that in vitro, slanMo cells from SSc patients produced less IL-12 than slanMo from HC. SlanMo are increased in SSc and may participate in the activation of cTfh cells in SSc.

Identifiants

pubmed: 35758259
pii: 6618461
doi: 10.1093/cei/uxac059
pmc: PMC9390843
doi:

Substances chimiques

Hormones 0
Interleukin-12 187348-17-0

Types de publication

Research Support, Non-U.S. Gov't Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-181

Commentaires et corrections

Type : CommentOn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
Ann Rheum Dis. 2019 Apr;78(4):539-550
pubmed: 30760472
Adv Rheumatol. 2021 May 22;61(1):27
pubmed: 34022965
Immunol Cell Biol. 2009 Nov-Dec;87(8):590-600
pubmed: 19721453
J Rheumatol. 2006 Feb;33(2):275-84
pubmed: 16465658
Sci Transl Med. 2018 Mar 7;10(431):
pubmed: 29514998
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321259
Immunol Lett. 2018 Mar;195:18-29
pubmed: 29126878
N Engl J Med. 2009 May 7;360(19):1989-2003
pubmed: 19420368
Blood. 2010 Jan 21;115(3):e10-9
pubmed: 19965649
Int J Rheum Dis. 2017 Oct;20(10):1551-1561
pubmed: 28952189
J Dermatol Sci. 2017 Aug;87(2):110-115
pubmed: 28499587
Expert Rev Clin Immunol. 2019 Jul;15(7):753-764
pubmed: 31046487
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
Pathobiology. 1999;67(5-6):287-90
pubmed: 10725804
J Allergy Clin Immunol. 2018 Jun;141(6):2276-2279.e3
pubmed: 29366702
J Dermatol. 2016 Aug;43(8):954-7
pubmed: 26945563
Immunity. 2006 Jun;24(6):767-777
pubmed: 16782032
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3901-10
pubmed: 27298374
Immunity. 2010 Sep 24;33(3):375-86
pubmed: 20832340
Arthritis Rheumatol. 2015 Apr;67(4):988-99
pubmed: 25581113
Immunity. 2015 Jun 16;42(6):1159-70
pubmed: 26070486
Blood. 2010 Oct 21;116(16):e74-80
pubmed: 20628149
J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9
pubmed: 21377044
J Autoimmun. 2013 Feb;40:1-8
pubmed: 22890025
Front Immunol. 2018 Jun 21;9:1352
pubmed: 29977237
J Autoimmun. 2021 Jan;116:102547
pubmed: 33039247
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Immunity. 2009 Jul 17;31(1):158-69
pubmed: 19592276
Clin Rheumatol. 2017 Jul;36(7):1649-1654
pubmed: 28293753
N Engl J Med. 2014 Jan 30;370(5):433-43
pubmed: 24350901

Auteurs

Laure Ricard (L)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Déborah Eshagh (D)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Lama Siblany (L)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Frédéric de Vassoigne (F)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Florent Malard (F)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Charlotte Laurent (C)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Pauline Beurier (P)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.

Vincent Jachiet (V)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Sébastien Rivière (S)

AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Olivier Fain (O)

AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Mohamad Mohty (M)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Béatrice Gaugler (B)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service d'Hématologie clinique, Paris, France.

Arsène Mekinian (A)

Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH